Livedo reticularis with retiform purpura associated with gefitinib (Iressa
作者： Jonathan E. Blume , Craig C. Miller
DOI: 10.1111/J.1365-4632.2007.03319.X
关键词:
摘要:
sci-hub.se 参考文章(10)
Ichiro Kurokawa, Kazuo Endo, Masataka Hirabayashi, Purpuric drug eruption possibly due to gefinitib (Iressa International Journal of Dermatology. ,vol. 44, pp. 167- 168 ,(2004) , 10.1111/J.1365-4632.2005.02185.X
Fortunato Ciardiello, Ferdinando De Vita, Michele Orditura, Giampaolo Tortora, The role of EGFR inhibitors in nonsmall cell lung cancer. Current Opinion in Oncology. ,vol. 16, pp. 130- 135 ,(2004) , 10.1097/00001622-200403000-00008
Shigenori Kanazawa, Kazuyuki Yamaguchi, Yoshimi Kinoshita, Mikiko Muramatsu, Yutaka Komiyama, Shosaku Nomura, Gefitinib affects functions of platelets and blood vessels via changes in prostanoids balance. Clinical and Applied Thrombosis-Hemostasis. ,vol. 11, pp. 429- 434 ,(2005) , 10.1177/107602960501100409
Mi-Woo Lee, Chul-Won Seo, Sang-We Kim, Hwa-Jeong Yang, Hae-Woong Lee, Jee-Ho Choi, Kee-Chan Moon, Jai-Kyoung Koh, Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor. Acta Dermato-venereologica. ,vol. 84, pp. 23- 26 ,(2003) , 10.1080/00015550310005898
R. Van Doorn, G. Kirtschig, E. Scheffer, T.J. Stoof, G. Giaccone, Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. British Journal of Dermatology. ,vol. 147, pp. 598- 601 ,(2002) , 10.1046/J.1365-2133.2002.04864.X
Neal J. Meropol, Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target. Journal of Clinical Oncology. ,vol. 23, pp. 1791- 1793 ,(2005) , 10.1200/JCO.2005.10.951
Mark B. Gibbs, Joseph C. English, Matthew J. Zirwas, Livedo reticularis: An update Journal of the American Academy of Dermatology. ,vol. 52, pp. 1009- 1019 ,(2005) , 10.1016/J.JAAD.2004.11.051
W. Jacot, D. Bessis, E. Jorda, M. Ychou, M. Fabbro, J-L. Pujol, B. Guillot, Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours British Journal of Dermatology. ,vol. 151, pp. 238- 241 ,(2004) , 10.1111/J.1365-2133.2004.06026.X
Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara, Gang Chen, W. David McGuinn, David Morse, Sophia Abraham, Atiqur Rahman, Chenyi Liang, Richard Lostritto, Amy Baird, Richard Pazdur, United States Food and Drug Administration Drug Approval Summary: Gefitinib (ZD1839; Iressa) Tablets Clinical Cancer Research. ,vol. 10, pp. 1212- 1218 ,(2004) , 10.1158/1078-0432.CCR-03-0564
M.K. Mohamed, S. Ramalingam, Y. Lin, W. Gooding, C.P. Belani, Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer Annals of Oncology. ,vol. 16, pp. 780- 785 ,(2005) , 10.1093/ANNONC/MDI157